Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO
Iambic Therapeutics is maintaining the momentum generated by its recent megaround and Big Pharma partnerships by gearing up to go public. The San Diego-based AI biotech has yet to announce how many shares it’s planning to offer—or at what price—but the …